Atypical Presentation of Chronic Granulomatous Disease in a Child
DOI:
https://doi.org/10.6092/1828-6550/APMB.105.2.2017.A1Palabras clave:
chronic granulomatous disease, anemia, immunodeficency, granulomatous inflammationResumen
Chronic granulomatous disease is a rare, inherited immunodeficiency caused by deletions or mutations in genes that encode subunits of the NADPH oxidase complex. The pattern of chronic granulomatous disease inheritance can be X-linked (about 70% of cases) or autosomal recessive. The basic defect lies in phagocytic cells (neutrophils and monocytes) which fail to effectively destroy invading bacteria and fungi. Also, a dysregulated immune response, characterized by extensive granulomatous inflammation of visceral organs, develops in patients. This immunodeficiency is characterized by repeated suppurative infections mainly located in the lungs, skin, and lymph nodes, but also affecting other organs. The major agents involved in the infections are catalase positive bacteria, mycobacteria, fungi, and other opportunistic germs. Diagnosis is based on clinical suspicion and confirmed by nitroblue tetrazolium test or flow cytometry that demonstrate the inability of phagocytes from affected individuals to produce superoxides. The treatment of chronic granulomatous disease involves, in addition to general care such as the prevention of infections and vaccinations, the use of sulfamethoxazole–trimethoprim in combination with itraconazole for prophylaxis. We report the case of a 3-year-old boy with medical history of recurrent respiratory infections, anemia, growth failure, elevated inflammatory markers and occasional rectal bleeding. He was admitted to our department for a suspected chronic bowel inflammatory disease. Clinical history, lymph nodes involvement and the discovery of intestinal granulomas on biopsies confirmed the diagnosis of chronic granulomatous disease.Referencias
Van Den Berg, J.M., Van Koppen, E., Åhlin, A., Belohradsky, B.H., Bernatowska, E., Corbeel L., et al. (2009) Chronic Granulomatous Disease: The European Experience. PLoS ONE4(4),e5234. doi:10.1371/journal.pone.0005234.
Rosenzweig, S.D. (2008) Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol, 28 (suppl 1),S67–S72. doi: 10.1007/s10875-007-9160-5.
Rosenzweig, S.D. (2009) Chronic granulomatous disease: complications and management. Expert Review of Clinical Immunology 5(1),45–53. doi: 10.1586/1744666X.5.1.45
Schäppi, M.G., Jaquet, V., Belli, D.C., Krause, K.H. (2008) Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 30,255–271. doi: 10.1007/s00281-008-0119-2.
Towbin, A.J., Chaves, I. (2010) Chronic granulomatous disease. Pediatr Radiol 40,657–668. doi: 10.1007/s00247-009-1503-3
Alimchandani, M., Lai, J.P., Aung, P.P., Khangura, S., Kamal, N., Gallin, J.I., Holland, S.M., Malech, H.L., Heller, T., Miettinen, M., Quezado, M.M. (2013) Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol 37,1365–1372. doi: 10.1097/PAS.0b013e318297427d.
Marciano, B.E., Rosenzweig, S.D., Kleiner, D.E., et al. (2004) Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114,462–468. PMID: 15286231
Rosenbaum, B.E., Shenoy, R., Vuppula, S., Thomas, K., Moy, L., Kaul A. (2016) Colitis as the Sole Initial Presentation of Chronic Granulomatous Disease: Histopathologic Clues to Diagnosis. Pediatr Infect Dis J. Nov 35(11),1229-1231. doi: 10.1097/INF.0000000000001284
Descargas
Publicado
Número
Sección
Licencia

This work is licensed under a Creative Commons Attribution 4.0 International License.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).